Management of Urinary Tract Muscle Spasms

Introduction to Treatment Options

Calcium channel blockers like diltiazem or nifedipine can be used as sphincter muscle relaxers, suggesting a potential role for amlodipine in managing urinary tract muscle spasms, according to the International Children's Continence Society 1
Amlodipine is primarily indicated for hypertension and angina, and its use for urinary tract muscle spasms would be an off-label application 2

Alpha-blockers are more commonly used for facilitating bladder emptying, according to the International Children's Continence Society 1
Calcium channel blockers like diltiazem and nifedipine have demonstrated effectiveness in treating anal fissures, a condition characterized by smooth muscle spasms 3

Calcium channel blockers, such as amlodipine, work by selectively blocking calcium channels in vascular smooth muscle, causing vasodilation in peripheral and coronary vascular beds 4
The most commonly reported side effects of calcium channel blockers include peripheral edema, headache, flushing, dizziness, and fatigue 5
Peripheral edema is the primary side effect of concern with calcium channel blockers like amlodipine, according to the European Society of Cardiology guidelines 5

The following guidelines do not list hematuria among the adverse effects of calcium channel blockers: Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines, American College of Cardiology (ACC) and American Heart Association (AHA) 2017 guidelines, and the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 6, 7, 8
Dihydropyridine calcium channel blockers like amlodipine may exacerbate edema and potentially increase proteinuria, but do not mention hematuria, according to the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines 9
If a patient on amlodipine presents with hematuria, clinicians should consider other more likely causes of hematuria, review the patient's complete medication list, and perform appropriate diagnostic workup, as suggested by the 2017 ACC/AHA guidelines on hypertension management and the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 7, 8
Muscle weakness is not listed among the common adverse effects of calcium channel blockers, according to the Mayo Clinic Proceedings 10
While amlodipine is unlikely to cause muscle weakness or wasting as a common side effect, isolated case reports of neuromuscular complications should be considered in context of the medication's extensive clinical use and generally favorable safety profile 4, 11

Amlodipine seems to have renoprotective effects and can even increase eGFR in CKD patients, suggesting favorable systemic effects, as noted by the British Journal of Pharmacology 12
Clinicians should be aware of rare cases of neuromuscular complications and consider evaluating for other causes, checking for drug interactions, particularly with statins 11